Chemours Co financial data

Symbol
CC on NYSE
Location
1007 Market Street, Wilmington, DE
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Chemours Company, LLC (to 4/21/2015)
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 153 % -10.9%
Quick Ratio 59 % -18.9%
Debt-to-equity 959 % +61.8%
Return On Equity 15.6 %
Return On Assets 1.48 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 149M shares +0.81%
Common Stock, Shares, Outstanding 149M shares +0.69%
Entity Public Float 5.5B USD +10%
Common Stock, Value, Issued 2M USD 0%
Weighted Average Number of Shares Outstanding, Basic 149M shares +0.21%
Weighted Average Number of Shares Outstanding, Diluted 150M shares +0.69%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 5.74B USD -8.87%
Research and Development Expense 108M USD -7.69%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 91M USD
Income Tax Expense (Benefit) -25M USD -143%
Net Income (Loss) Attributable to Parent 116M USD
Earnings Per Share, Basic 0.78 USD/shares
Earnings Per Share, Diluted 0.76 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 604M USD -18.2%
Accounts Receivable, after Allowance for Credit Loss, Current 788M USD +0.77%
Inventory, Net 1.37B USD -5.39%
Assets, Current 2.94B USD -13%
Property, Plant and Equipment, Net 3.16B USD -1.03%
Operating Lease, Right-of-Use Asset 251M USD +2.87%
Goodwill 102M USD 0%
Other Assets, Noncurrent 630M USD +13.9%
Assets 7.25B USD -5.37%
Accounts Payable, Current 938M USD -5.44%
Employee-related Liabilities, Current 73M USD -6.41%
Accrued Liabilities, Current 382M USD -58.9%
Liabilities, Current 1.56B USD -28.9%
Long-term Debt and Lease Obligation 3.95B USD +9.63%
Deferred Income Tax Liabilities, Net 41M USD -29.3%
Operating Lease, Liability, Noncurrent 195M USD -0.51%
Other Liabilities, Noncurrent 327M USD -0.61%
Liabilities 6.52B USD -4.76%
Accumulated Other Comprehensive Income (Loss), Net of Tax -347M USD -23.1%
Retained Earnings (Accumulated Deficit) 1.83B USD -1.93%
Stockholders' Equity Attributable to Parent 723M USD -10.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 725M USD -10.5%
Liabilities and Equity 7.25B USD -5.37%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -290M USD -134%
Net Cash Provided by (Used in) Financing Activities -54M USD +20.6%
Net Cash Provided by (Used in) Investing Activities -101M USD -4.12%
Common Stock, Shares Authorized 810M shares 0%
Common Stock, Shares, Issued 198M shares +0.7%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -454M USD -60.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 619M USD -34.5%
Deferred Tax Assets, Valuation Allowance 165M USD +1275%
Deferred Tax Assets, Gross 788M USD +56%
Operating Lease, Liability 261M USD +5.67%
Depreciation 290M USD -1.02%
Payments to Acquire Property, Plant, and Equipment 102M USD +12.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 50M USD +525%
Lessee, Operating Lease, Liability, to be Paid 321M USD +5.25%
Property, Plant and Equipment, Gross 9.44B USD -1.13%
Operating Lease, Liability, Current 53M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 55M USD +5.77%
Lessee, Operating Lease, Liability, to be Paid, Year One 69M USD +13.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +19.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 60M USD +3.45%
Lessee, Operating Lease, Liability, to be Paid, Year Three 47M USD +11.9%
Deferred Tax Assets, Operating Loss Carryforwards 200M USD +174%
Unrecognized Tax Benefits 73M USD +12.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 32M USD -11.1%
Additional Paid in Capital 1.05B USD +3.06%
Depreciation, Depletion and Amortization 295M USD -2.32%
Deferred Tax Assets, Net of Valuation Allowance 623M USD +26.4%
Share-based Payment Arrangement, Expense 17M USD 0%
Interest Expense 247M USD +43.6%